2023 Q4 Form 10-Q Financial Statement

#000149315223041280 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $29.00K $29.00K $2.187M
YoY Change -98.66% -98.67% -24.59%
Cost Of Revenue $12.00K $5.000K $736.0K
YoY Change -98.44% -99.32% -32.23%
Gross Profit $17.00K $24.00K $1.451M
YoY Change -98.78% -98.35% -20.01%
Gross Profit Margin 58.62% 82.76% 66.35%
Selling, General & Admin $2.428M $2.850M $6.965M
YoY Change -48.02% -59.08% 13.62%
% of Gross Profit 14282.35% 11875.0% 480.01%
Research & Development $0.00 $1.372M
YoY Change -100.0% -60.95%
% of Gross Profit 0.0% 94.56%
Depreciation & Amortization $601.0K $560.0K $840.0K
YoY Change -44.61% -33.33% 109.48%
% of Gross Profit 3535.29% 2333.33% 57.89%
Operating Expenses $3.029M $3.414M $9.127M
YoY Change -53.11% -62.59% -9.12%
Operating Profit -$3.012M -$3.390M -$7.676M
YoY Change -40.58% -55.84% -6.72%
Interest Expense -$193.0K $219.0K $550.0K
YoY Change -54.69% -60.18% -182.58%
% of Operating Profit
Other Income/Expense, Net $318.0K -$151.0K -$352.0K
YoY Change -77.51% -57.1% -4500.0%
Pretax Income -$2.887M -$3.540M -$8.028M
YoY Change -82.01% -55.9% -8.82%
Income Tax
% Of Pretax Income
Net Earnings -$2.915M -$3.709M -$8.028M
YoY Change -82.11% -53.8% -8.82%
Net Earnings / Revenue -10051.72% -12789.66% -367.08%
Basic Earnings Per Share -$0.68 -$0.08
Diluted Earnings Per Share -$0.22 -$0.68 -$78.62K
COMMON SHARES
Basic Shares Outstanding 16.41M shares 4.501M shares 102.4M shares
Diluted Shares Outstanding 5.421M shares 2.553M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.353M $920.0K $921.0K
YoY Change 79.21% -0.11% -74.82%
Cash & Equivalents $4.353M $918.0K $921.0K
Short-Term Investments
Other Short-Term Assets $331.0K $400.0K $738.0K
YoY Change -45.29% -45.8% -18.45%
Inventory
Prepaid Expenses $738.0K
Receivables $1.438M
Other Receivables $0.00
Total Short-Term Assets $4.684M $1.318M $3.097M
YoY Change 15.43% -57.44% -48.86%
LONG-TERM ASSETS
Property, Plant & Equipment $261.0K $39.00K $582.0K
YoY Change -51.4% -93.3% -89.19%
Goodwill $19.76M
YoY Change
Intangibles $117.0K $97.00K $2.966M
YoY Change -85.95% -96.73%
Long-Term Investments
YoY Change
Other Assets $259.0K $259.0K $306.0K
YoY Change -15.36% -15.36% -3.47%
Total Long-Term Assets $6.155M $6.750M $31.69M
YoY Change -69.88% -78.7% 6.21%
TOTAL ASSETS
Total Short-Term Assets $4.684M $1.318M $3.097M
Total Long-Term Assets $6.155M $6.750M $31.69M
Total Assets $10.84M $8.068M $34.78M
YoY Change -55.74% -76.8% -3.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.408M $2.706M $3.833M
YoY Change -69.64% -29.4% -47.36%
Accrued Expenses $3.992M $2.080M $3.851M
YoY Change 142.53% -45.99% 73.16%
Deferred Revenue $1.549M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.787M $2.610M $4.171M
YoY Change -69.21% -37.43% 10327.5%
Total Short-Term Liabilities $7.188M $8.457M $16.40M
YoY Change -56.52% -48.42% -9.61%
LONG-TERM LIABILITIES
Long-Term Debt $362.0K $140.0K $150.0K
YoY Change -70.21% -6.67% -82.86%
Other Long-Term Liabilities $164.0K $180.0K $1.705M
YoY Change -89.63% -89.44% -30.8%
Total Long-Term Liabilities $526.0K $320.0K $1.855M
YoY Change -81.19% -82.75% -44.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.188M $8.457M $16.40M
Total Long-Term Liabilities $526.0K $320.0K $1.855M
Total Liabilities $7.714M $8.783M $18.25M
YoY Change -60.08% -51.88% -15.03%
SHAREHOLDERS EQUITY
Retained Earnings -$175.6M -$172.7M -$137.4M
YoY Change 14.44% 25.68%
Common Stock $2.000K $1.000K $10.00K
YoY Change -83.33% -90.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.125M -$715.0K $16.53M
YoY Change
Total Liabilities & Shareholders Equity $10.84M $8.068M $34.78M
YoY Change -55.74% -76.8% -3.08%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$2.915M -$3.709M -$8.028M
YoY Change -82.11% -53.8% -8.82%
Depreciation, Depletion And Amortization $601.0K $560.0K $840.0K
YoY Change -44.61% -33.33% 109.48%
Cash From Operating Activities -$2.127M -$1.930M -$4.973M
YoY Change -38.01% -61.19% 8.04%
INVESTING ACTIVITIES
Capital Expenditures $26.00K $40.00K -$191.0K
YoY Change -92.49% -120.94% -91.89%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$36.00K -$30.00K -$191.0K
YoY Change -89.6% -84.29% -91.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.587M -640.0K 538.0K
YoY Change 5.71% -218.96% -87.09%
NET CHANGE
Cash From Operating Activities -2.127M -1.930M -4.973M
Cash From Investing Activities -36.00K -30.00K -191.0K
Cash From Financing Activities 5.587M -640.0K 538.0K
Net Change In Cash 3.424M -2.600M -4.626M
YoY Change 127.06% -43.8% 65.75%
FREE CASH FLOW
Cash From Operating Activities -$2.127M -$1.930M -$4.973M
Capital Expenditures $26.00K $40.00K -$191.0K
Free Cash Flow -$2.153M -$1.970M -$4.782M
YoY Change -43.0% -58.8% 112.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 VERB Financing Costs
FinancingCosts
usd
VERB Financing Costs
FinancingCosts
usd
CY2023Q3 VERB Deemed Dividend Due To Warrant Reset
DeemedDividendDueToWarrantReset
usd
CY2022Q3 VERB Deemed Dividend Due To Warrant Reset
DeemedDividendDueToWarrantReset
usd
VERB Deemed Dividend Due To Warrant Reset
DeemedDividendDueToWarrantReset
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001566610
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
usd
VERB Stock Issued During Period Value Reverse Stock Splits
StockIssuedDuringPeriodValueReverseStockSplits
usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
VERB Financing Costs
FinancingCosts
usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
VERB Repayments Of Convertible Notes Payable To Related Parties
RepaymentsOfConvertibleNotesPayableToRelatedParties
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
VERB Fair Value Of Common Shares Issued As Payment On Notes Payable
FairValueOfCommonSharesIssuedAsPaymentOnNotesPayable
usd
VERB Fair Value Of Common Stock Received In Exchange For Employees Payroll Taxes
FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes
usd
VERB Accrued Capitalized Software Development Costs
AccruedCapitalizedSoftwareDevelopmentCosts
usd
VERB Discount Recognized From Notes Payable
DiscountRecognizedFromNotesPayable
usd
VERB Derecognition Of Operating Lease Rightofuse Assets Continuing Operations
DerecognitionOfOperatingLeaseRightofuseAssetsContinuingOperations
usd
VERB Derecognition Of Operating Lease Liabilities Continuing Operations
DerecognitionOfOperatingLeaseLiabilitiesContinuingOperations
usd
VERB Derecognition Of Other Assets And Liabilities Related To Lease Termination
DerecognitionOfOtherAssetsAndLiabilitiesRelatedToLeaseTermination
usd
VERB Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability Continuing Operations
RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiabilityContinuingOperations
usd
VERB Derecognition Of Operating Lease Right Of Use Assets
DerecognitionOfOperatingLeaseRightOfUseAssets
usd
VERB Derecognition Of Operating Lease Liabilities
DerecognitionOfOperatingLeaseLiabilities
usd
VERB Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability
RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2023Q3 VERB Lessee Operating Lease Liability Payments Due Four And After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueFourAndAfterYearFour
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38834
dei Entity Registrant Name
EntityRegistrantName
Verb Technology Company, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1118043
dei City Area Code
CityAreaCode
(855)
dei Local Phone Number
LocalPhoneNumber
250-2300
dei Entity Address Address Line1
EntityAddressAddressLine1
3401 North Thanksgiving Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 240
dei Entity Address City Or Town
EntityAddressCityOrTown
Lehi
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84043
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16408287 shares
CY2023Q3 us-gaap Cash
Cash
918000 usd
CY2022Q4 us-gaap Cash
Cash
2429000 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1323000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
400000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
306000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1318000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4058000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
10467000 usd
CY2023Q3 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
4584000 usd
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
6176000 usd
CY2023Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1528000 usd
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1528000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
533000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
243000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1354000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
97000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
83000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
259000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
293000 usd
CY2023Q3 us-gaap Assets
Assets
8068000 usd
CY2022Q4 us-gaap Assets
Assets
24492000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2706000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3975000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2483000 usd
CY2023Q3 VERB Liabilities Of Discontinued Operations
LiabilitiesOfDiscontinuedOperations
219000 usd
CY2022Q4 VERB Liabilities Of Discontinued Operations
LiabilitiesOfDiscontinuedOperations
1641000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2080000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1287000 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
764000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
764000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1334000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
65000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
355000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
12000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
222000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8457000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16530000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
142000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1215000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
184000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1581000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
8783000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
19326000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7868774 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7868774 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2918017 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2918017 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
171991000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
158629000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172707000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153464000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-715000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5166000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8068000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24492000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
5000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
24000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
2000 usd
us-gaap Gross Profit
GrossProfit
27000 usd
us-gaap Gross Profit
GrossProfit
2000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
564000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
438000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1730000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
524000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2850000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5126000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9080000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15019000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3414000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
5564000 usd
us-gaap Operating Expenses
OperatingExpenses
10810000 usd
us-gaap Operating Expenses
OperatingExpenses
15543000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3390000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5562000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10783000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15541000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
844000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000 usd
VERB Financing Costs
FinancingCosts
-1239000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
219000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
289000 usd
us-gaap Interest Expense
InterestExpense
989000 usd
us-gaap Interest Expense
InterestExpense
950000 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4000 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
198000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
210000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2360000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-151000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-91000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1174000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1394000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-3541000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5653000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11957000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-14147000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-168000 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2375000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-7122000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-7244000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3709000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8028000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19079000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21391000 usd
VERB Deemed Dividend Due To Warrant Reset
DeemedDividendDueToWarrantReset
164000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3709000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8028000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19243000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21391000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.30
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5420884 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5420884 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2552755 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2552755 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4690744 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4690744 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2301020 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2301020 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5166000 usd
us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
6628000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1932000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
200000 usd
VERB Stock Issued During Period Value For Settlement Of Accrued Expenses And Litigation
StockIssuedDuringPeriodValueForSettlementOfAccruedExpensesAndLitigation
346000 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4092000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19079000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-715000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13322000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13322000 usd
us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
20150000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
377000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1461000 usd
VERB Stock Issued During Period Value To Settle Accrued Expenses
StockIssuedDuringPeriodValueToSettleAccruedExpenses
450000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
2163000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21391000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
16532000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
16532000 usd
us-gaap Net Income Loss
NetIncomeLoss
-19079000 usd
us-gaap Net Income Loss
NetIncomeLoss
-21391000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-7122000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-7244000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1985000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3668000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
238000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
238000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
182000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
367000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
210000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2360000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1730000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
524000 usd
VERB Financing Costs
FinancingCosts
-1239000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
263000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-14000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-52000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
161000 usd
VERB Increase Decrease In Operating Lease Rightofuse Assets
IncreaseDecreaseInOperatingLeaseRightofuseAssets
-170000 usd
VERB Increase Decrease In Operating Lease Rightofuse Assets
IncreaseDecreaseInOperatingLeaseRightofuseAssets
-191000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-13000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
265000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1089000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-377000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-63000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-269000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6619000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11223000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1855000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-4752000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
239000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4299000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
82000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-275000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4401000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
4750000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-1000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6628000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20150000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6000000 usd
VERB Repayments Of Convertible Notes Payable To Related Parties
RepaymentsOfConvertibleNotesPayableToRelatedParties
40000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
383000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1350000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
2740000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
377000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
445000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4855000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
23342000 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-2367000 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-2981000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1511000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2429000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
937000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
918000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
921000 usd
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
6500000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
4750000 usd
CY2023Q2 us-gaap Discontinued Operation Amounts Of Material Contingent Liabilities Remaining
DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining
1750000 usd
us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
participants in the Creator program can earn between 5% and 20% of their gross sales at no cost and no risk to the Creators selected to participate in the program
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11957000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6619000 usd
CY2023Q3 us-gaap Cash
Cash
918000 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
901275 shares
CY2023Q1 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
6578000 usd
CY2023Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
622000 usd
CY2023Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
105300 shares
CY2023Q3 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
50000 usd
CY2023Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
27000 usd
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-11-07
VERB Employee Retention Credit Provisions
EmployeeRetentionCreditProvisions
1528000 usd
CY2023Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1528000 usd
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1528000 usd
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
6500000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
4750000 usd
CY2023Q2 us-gaap Discontinued Operation Amounts Of Material Contingent Liabilities Remaining
DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining
1750000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6176000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
249000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zOVv53MzSXx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zuuVgq2vrGfj">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Significant estimates include assumptions made in analysis of reserves for allowance of doubtful accounts, inventory, assumptions made in purchase price allocations, impairment testing of long-term assets, realization of deferred tax assets, determining fair value of derivative liabilities, and valuation of equity instruments issued for services. Amounts could materially change in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
VERB Plat Form Fee Description
PlatFormFeeDescription
All sales run through our ecommerce facility on MARKET.live from which we deduct a platform fee that ranges from 10% to 20% of gross sales, with an average of approximately 15%
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 usd
CY2022 us-gaap Goodwill Impairment Loss Net Of Tax
GoodwillImpairmentLossNetOfTax
10183000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
9581000 usd
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
6500000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
4750000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5441000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-7122000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-7244000 usd
CY2023Q3 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
263000 usd
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zunX8MfWUHRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zDTnjSCHFale">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the consolidated balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses Level 2 inputs for its valuation methodology for the derivative liabilities as their fair values were determined by using a Binomial pricing model. The Company’s derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjusted to fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zfUHZXbSVksa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zTCD0ILHHE8">Concentration of Credit and Other Risks</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. Cash is deposited with a limited number of financial institutions. The balances held at any one financial institution at times may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits of up to $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20230930_zP6hpWeEUZDk" title="FDIC insured amount">250</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s concentration of credit risk includes its concentrations from key customers and vendors. The details of these significant customers and vendors are presented in the following table for the nine months ended September 30, 2023 and 2022:</span></p> <p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zUiqtt9cUk7k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zrCqrTmPmXde" style="display: none">SCHEDULE OF CONCENTRATION RISK</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine Months Ended September 30,</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left; width: 40%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; text-align: center; width: 2%; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 28%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center; width: 2%; vertical-align: bottom"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 28%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Company’s largest customers are presented below as a percentage of the aggregate</b></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues and Accounts receivable</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No customers individually over <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesAndAccountsReceivablesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomersMember_zbhalo450p24" title="Revenues and Accounts receivable">10</span>% and in the aggregate</span></td> <td style="text-align: center; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No customers individually over <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesAndAccountsReceivablesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomersMember_zwBNfxvlimvl" title="Revenues and Accounts receivable">10</span>% and in the aggregate</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Company’s largest vendors are presented below as a percentage of the aggregate</b></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One vendor that accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FirstVendorMember_zDoJ5IiPlk33" title="Purchases">28</span>% of its purchases individually and in the aggregate</span></td> <td style="text-align: center; vertical-align: bottom"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two vendors that accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FirstVendorMember_ziBd2YyXEdLh" title="Purchases">27</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondVendorMember_zzHH3cjEVYPa" title="Purchases">61</span>%, respectively, of its purchases individually and in the aggregate</span></td></tr> </table> <p id="xdx_8AB_zjaKSmVg4ikf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
263000 usd
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
932000 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4584000 usd
us-gaap Interest Paid Net
InterestPaidNet
242000 usd
us-gaap Interest Paid Net
InterestPaidNet
203000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000 usd
VERB Fair Value Of Common Shares Issued To Settle Accrued Expenses
FairValueOfCommonSharesIssuedToSettleAccruedExpenses
346000 usd
VERB Fair Value Of Common Shares Issued To Settle Accrued Expenses
FairValueOfCommonSharesIssuedToSettleAccruedExpenses
450000 usd
VERB Fair Value Of Common Shares Issued As Payment On Notes Payable
FairValueOfCommonSharesIssuedAsPaymentOnNotesPayable
4092000 usd
VERB Fair Value Of Common Stock Received In Exchange For Employees Payroll Taxes
FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes
8000 usd
VERB Accrued Capitalized Software Development Costs
AccruedCapitalizedSoftwareDevelopmentCosts
291000 usd
VERB Discount Recognized From Notes Payable
DiscountRecognizedFromNotesPayable
300000 usd
VERB Derecognition Of Operating Lease Rightofuse Assets Continuing Operations
DerecognitionOfOperatingLeaseRightofuseAssetsContinuingOperations
1186000 usd
VERB Derecognition Of Operating Lease Liabilities Continuing Operations
DerecognitionOfOperatingLeaseLiabilitiesContinuingOperations
1870000 usd
VERB Derecognition Of Other Assets And Liabilities Related To Lease Termination
DerecognitionOfOtherAssetsAndLiabilitiesRelatedToLeaseTermination
421000 usd
VERB Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability Continuing Operations
RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiabilityContinuingOperations
245000 usd
VERB Discount Recognized From Advances On Future Receipts
DiscountRecognizedFromAdvancesOnFutureReceipts
558000 usd
VERB Discount Recognized From Advances On Future Receipts
DiscountRecognizedFromAdvancesOnFutureReceipts
900000 usd
VERB Derecognition Of Operating Lease Right Of Use Assets
DerecognitionOfOperatingLeaseRightOfUseAssets
543000 usd
VERB Derecognition Of Operating Lease Liabilities
DerecognitionOfOperatingLeaseLiabilities
521000 usd
VERB Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability
RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability
212000 usd
CY2023Q3 VERB Accrued Other Capitalized Software Development Costs
AccruedOtherCapitalizedSoftwareDevelopmentCosts
605000 usd
CY2022Q4 VERB Accrued Other Capitalized Software Development Costs
AccruedOtherCapitalizedSoftwareDevelopmentCosts
604000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6176000 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4348000 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
23000 usd
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
2760000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1615000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
594000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2377000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1445000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
168000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4584000 usd
CY2021Q3 VERB Break Up Fee Payable
BreakUpFeePayable
1000000 usd
CY2021Q3 VERB Business Combination Consideration Transferred Assumption Description
BusinessCombinationConsiderationTransferredAssumptionDescription
the purchase price for the Primary Contractor would have been $12,000, which could be paid in cash and/or stock, although the final terms of the acquisition if pursued will be set forth in the final executed SPA
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
6500000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
4750000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5441000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
1024000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets
299000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill1
DisposalGroupIncludingDiscontinuedOperationGoodwill1
9581000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets
DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
886000 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
11790000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
663000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Other Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
1340000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
480000 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
2483000 usd
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
2184000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-168000 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2375000 usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
3814000 usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
7274000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
121000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
334000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M1D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.090 pure
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040 pure
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
243000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1354000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
65000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
355000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
184000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1581000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
249000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1936000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
23000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
92000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
96000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
75000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
286000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
37000 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5830000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
269000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1989000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
41000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
311000 usd
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
37000 usd
CY2023Q3 VERB Advances On Future Receipts Net
AdvancesOnFutureReceiptsNet
219000 usd
CY2022Q4 VERB Advances On Future Receipts Net
AdvancesOnFutureReceiptsNet
1641000 usd
CY2023Q3 VERB Notes Payable Related Parties Debt Discount
NotesPayableRelatedPartiesDebtDiscount
-171000 usd
CY2022Q4 VERB Notes Payable Related Parties Debt Discount
NotesPayableRelatedPartiesDebtDiscount
-408000 usd
CY2023Q3 VERB Notes Payable Related Parties Debt Issuance Costs
NotesPayableRelatedPartiesDebtIssuanceCosts
-127000 usd
CY2022Q4 VERB Notes Payable Related Parties Debt Issuance Costs
NotesPayableRelatedPartiesDebtIssuanceCosts
-309000 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
2753000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
7018000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
142000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1215000 usd
CY2023Q3 VERB Notes Payables Current
NotesPayablesCurrent
2611000 usd
CY2022Q4 VERB Notes Payables Current
NotesPayablesCurrent
5803000 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
75000 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
67000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
55000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
103000 usd
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
89000 usd
CY2022Q3 us-gaap Interest Expense Other
InterestExpenseOther
119000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
219000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
289000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
238000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
238000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
182000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
367000 usd
us-gaap Interest Expense Other
InterestExpenseOther
569000 usd
us-gaap Interest Expense Other
InterestExpenseOther
345000 usd
us-gaap Interest Expense
InterestExpense
989000 usd
us-gaap Interest Expense
InterestExpense
950000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
12000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
222000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
210000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2360000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
12000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
222000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3155000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
210000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2360000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
12000 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
795000 usd
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
901275 shares
CY2023Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
8.00
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6578000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.60
CY2023Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
8.00
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split of its outstanding shares of common stock at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-forty (1-for-40) split. On April 18, 2023, the Company implemented the 1-for-40 reverse stock split (the “Reverse Stock Split”) of its common stock. The Company’s common stock commenced trading on a post- reverse stock split basis on April 19, 2023. As a result of the Reverse Stock Split, every forty (40) shares of the Company’s pre-Reverse Stock Split common stock were combined and reclassified into one share of common stock
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
89898 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.04
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
284761 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
198437 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
5.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
20650 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
40.49
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
155572 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
6.57
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
139054 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
52.11
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y4M13D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2028425 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
110597 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
60.48
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2056882 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
319434 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.99
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
319434 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.99
CY2023Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
440000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
954000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1795000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0429 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0124 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0337 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.362 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.436 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.495 pure
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
901275 shares
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
8.00
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.60
CY2023Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
8.00
CY2023Q1 VERB Deemed Dividend Due To Warrant Reset
DeemedDividendDueToWarrantReset
164000 usd
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
300000 usd
CY2021Q4 us-gaap Legal Fees
LegalFees
915000 usd
CY2023Q1 us-gaap Loss Contingency Settlement Agreement Court
LossContingencySettlementAgreementCourt
On March 1, 2023, BH and the Company entered into an out of court settlement and the Company agreed to pay $25 on execution of the settlement agreement and $6.25 per month over a period of 12 months with a total settlement amount of $100. The remaining unpaid settlement amount of $50 was accrued by the Company as of September 30, 2023
VERB Board Fees Expense
BoardFeesExpense
250000 usd
VERB Prepaid Board Fees Expense
PrepaidBoardFeesExpense
62000 usd

Files In Submission

Name View Source Status
verb-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001493152-23-041280-index-headers.html Edgar Link pending
0001493152-23-041280-index.html Edgar Link pending
0001493152-23-041280.txt Edgar Link pending
0001493152-23-041280-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
verb-20230930.xsd Edgar Link pending
verb-20230930_def.xml Edgar Link unprocessable
verb-20230930_lab.xml Edgar Link unprocessable
verb-20230930_pre.xml Edgar Link unprocessable